Avanos Medical, Inc.
AVNS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $536,384 | $564,264 | $660,613 | $732,320 |
| - Cash | $70,500 | $90,300 | $97,000 | $107,700 |
| + Debt | $133,700 | $137,300 | $140,900 | $170,200 |
| Enterprise Value | $599,584 | $611,264 | $704,513 | $794,820 |
| Revenue | $177,800 | $175,000 | $167,500 | $179,600 |
| % Growth | 1.6% | 4.5% | -6.7% | – |
| Gross Profit | $81,100 | $92,100 | $89,800 | $99,300 |
| % Margin | 45.6% | 52.6% | 53.6% | 55.3% |
| EBITDA | $10,000 | -$63,900 | $21,400 | -$406,600 |
| % Margin | 5.6% | -36.5% | 12.8% | -226.4% |
| Net Income | -$1,400 | -$76,800 | $6,600 | -$397,300 |
| % Margin | -0.8% | -43.9% | 3.9% | -221.2% |
| EPS Diluted | -0.03 | -1.66 | 0.14 | -8.64 |
| % Growth | 98.2% | -1,285.7% | 101.6% | – |
| Operating Cash Flow | $14,000 | $6,800 | $25,700 | $57,900 |
| Capital Expenditures | -$7,000 | -$11,000 | -$6,700 | -$4,800 |
| Free Cash Flow | $7,000 | -$4,200 | $19,000 | $53,100 |